Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces t hat it will release its financial results for the year ended 31 March 2020 on Tuesday 14 July 2020.
Omega will be hosting a live online presentation open to all investors on Wednesday 15 July at 4.30pm, delivered by Colin King, CEO.
The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management on its results whilst additionally providing an update on the business and current trading.
The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics plc via the following link:
For those investors who have already registered and added to meet the Company, they will automatically be invited.
Questions can be submitted pre-event via your IMC dashboard or in real-time during the presentation, via the “Ask a Question” function.
Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications.
A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned